SE7413833L - - Google Patents

Info

Publication number
SE7413833L
SE7413833L SE7413833A SE7413833A SE7413833L SE 7413833 L SE7413833 L SE 7413833L SE 7413833 A SE7413833 A SE 7413833A SE 7413833 A SE7413833 A SE 7413833A SE 7413833 L SE7413833 L SE 7413833L
Authority
SE
Sweden
Application number
SE7413833A
Other versions
SE415762B (sv
Inventor
R A Archer
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE7413833L publication Critical patent/SE7413833L/xx
Publication of SE415762B publication Critical patent/SE415762B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
SE7413833A 1973-11-05 1974-11-04 Forfarande for framstellnig av terapeutiskt verksamma hexahysrodibenso(b,d)-pyraner med hydroxi-och/eller alkanoyloxi-substituenter i 1-och 9-stellningarna SE415762B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/413,010 US3968125A (en) 1973-11-05 1973-11-05 Dihydroxyhexahydrodibenzo[b,d]pyrans

Publications (2)

Publication Number Publication Date
SE7413833L true SE7413833L (fr) 1975-05-06
SE415762B SE415762B (sv) 1980-10-27

Family

ID=23635420

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7413833A SE415762B (sv) 1973-11-05 1974-11-04 Forfarande for framstellnig av terapeutiskt verksamma hexahysrodibenso(b,d)-pyraner med hydroxi-och/eller alkanoyloxi-substituenter i 1-och 9-stellningarna

Country Status (26)

Country Link
US (1) US3968125A (fr)
JP (1) JPS6033835B2 (fr)
AR (1) AR202318A1 (fr)
AT (1) AT336012B (fr)
BE (1) BE821716A (fr)
BG (1) BG26387A3 (fr)
CA (1) CA1023753A (fr)
CH (1) CH605894A5 (fr)
CS (1) CS193507B2 (fr)
DD (1) DD116230A5 (fr)
DE (1) DE2451934C2 (fr)
DK (1) DK136719B (fr)
ES (1) ES431674A1 (fr)
FR (1) FR2249664B1 (fr)
GB (1) GB1487637A (fr)
HU (1) HU169193B (fr)
IE (1) IE40023B1 (fr)
IL (1) IL45644A (fr)
NL (1) NL7414439A (fr)
PH (1) PH11788A (fr)
PL (2) PL95748B1 (fr)
RO (1) RO71766A (fr)
SE (1) SE415762B (fr)
SU (1) SU524517A3 (fr)
YU (1) YU36515B (fr)
ZA (1) ZA745751B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1522057A (en) * 1975-11-03 1978-08-23 Pfizer 9-hydroxydibenzo(b,d)pyrans and intermediates therefor
US4051152A (en) * 1976-01-07 1977-09-27 Sharps Associates Oxo C-ring benzopyrans
US4087546A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiasthmatic drugs
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
US4054581A (en) * 1976-07-06 1977-10-18 Eli Lilly And Company Preparation of cis-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones and intermediates therefor
US4133819A (en) * 1977-06-17 1979-01-09 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4209520A (en) * 1977-06-17 1980-06-24 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4243674A (en) * 1978-06-12 1981-01-06 Pfizer Inc. 9-Hydroxydibenzo[b,d]pyrans and intermediates therefore
US4454144A (en) * 1982-06-21 1984-06-12 Pfizer Inc. Substituted dibenzo[b,d]pyran analgesics
JPS6299930U (fr) * 1985-12-12 1987-06-25
US8449908B2 (en) * 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
JP4202250B2 (ja) 2001-07-25 2008-12-24 バイオマリン ファーマシューティカル インコーポレイテッド 血液脳関門輸送を調節するための組成物および方法
US20050101590A1 (en) 2002-02-19 2005-05-12 Kiyoshi Yasui Antipruritics
EP3827747A1 (fr) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Système pharma-informatique
CA2663377A1 (fr) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Traitement des troubles hepatiques par l'administration de conjugues de proteine associee au recepteur (rap)
EP2176208B1 (fr) * 2007-07-30 2015-01-21 Zynerba Pharmaceuticals, Inc. Promédicaments de cannabidiol, compositions comprenant les promédicaments de cannabidiol et leurs procédés d'utilisation
EP2254601B1 (fr) 2008-02-08 2019-05-29 Nektar Therapeutics Conjugués d'oligomère et de cannabinoïde
US20090247619A1 (en) * 2008-03-06 2009-10-01 University Of Kentucky Cannabinoid-Containing Compositions and Methods for Their Use
EP2398500B1 (fr) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Sustème d'administration de médicament à base de glutathionne
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
US20200197357A1 (en) 2017-07-20 2020-06-25 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions and methods of lipophilic drugs
WO2019049145A1 (fr) 2017-09-11 2019-03-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions et procédés pour l'administration nasale de médicaments en direction du cerveau et en vue d'un effet systémique
EP3717014A1 (fr) 2017-11-29 2020-10-07 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Compositions de cannabinoïdes et méthodes
WO2020089905A1 (fr) 2018-11-04 2020-05-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions contenant des cannabinoïdes administrables par voie orale et procédés

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507885A (en) * 1966-03-25 1970-04-21 Hoffmann La Roche 3-alkyl-6h-dibenzo(b,d)pyrans
US3636058A (en) * 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones
CH558792A (de) * 1971-10-14 1975-02-14 Petrzilka Theodor Verfahren zur herstellung von tetrahydrodibenzopyranen.

Also Published As

Publication number Publication date
ES431674A1 (es) 1976-11-16
DE2451934A1 (de) 1975-05-07
SU524517A3 (ru) 1976-08-05
NL7414439A (nl) 1975-05-07
CS193507B2 (en) 1979-10-31
ATA886374A (de) 1976-08-15
IE40023B1 (en) 1979-02-28
DK136719C (fr) 1978-04-24
IL45644A0 (en) 1974-11-29
PL95748B1 (pl) 1977-11-30
FR2249664A1 (fr) 1975-05-30
DK136719B (da) 1977-11-14
PH11788A (en) 1978-07-05
IE40023L (en) 1975-05-05
RO71766A (fr) 1982-12-06
GB1487637A (en) 1977-10-05
HU169193B (fr) 1976-10-28
BG26387A3 (bg) 1979-03-15
JPS6033835B2 (ja) 1985-08-05
US3968125A (en) 1976-07-06
CH605894A5 (fr) 1978-10-13
BE821716A (fr) 1975-04-30
ZA745751B (en) 1976-04-28
DD116230A5 (fr) 1975-11-12
CA1023753A (fr) 1978-01-03
AU7321274A (en) 1976-03-18
YU265874A (en) 1982-02-25
DE2451934C2 (de) 1983-10-06
DK573274A (fr) 1975-07-07
SE415762B (sv) 1980-10-27
AR202318A1 (es) 1975-05-30
AT336012B (de) 1977-04-12
PL93908B1 (fr) 1977-07-30
YU36515B (en) 1984-02-29
FR2249664B1 (fr) 1978-03-24
JPS5071678A (fr) 1975-06-13
IL45644A (en) 1978-03-10

Similar Documents

Publication Publication Date Title
AU465372B2 (fr)
AU474593B2 (fr)
AU474511B2 (fr)
FR2249664B1 (fr)
AU474838B2 (fr)
AR201229Q (fr)
AU472848B2 (fr)
AU476696B2 (fr)
AU461342B2 (fr)
AU477824B2 (fr)
CH563307A5 (fr)
BG19740A1 (fr)
CH566005A5 (fr)
CH566609A5 (fr)
CH564257A5 (fr)
CH563569A5 (fr)
CH566632A5 (fr)
CH560043A5 (fr)
CH562978A5 (fr)
CH562456A5 (fr)
CH561642A5 (fr)
CH560606A5 (fr)
CH1655873A4 (fr)
CH1003373A4 (fr)
CH565302A5 (fr)